Detalhe da pesquisa
1.
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey.
Blood
; 140(26): 2773-2787, 2022 12 29.
Artigo
Inglês
| MEDLINE | ID: mdl-36126318
2.
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA).
Haematologica
; 108(1): 22-33, 2023 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35545919
3.
A High-Risk Profile for Invasive Fungal Infections Is Associated with Altered Nasal Microbiota and Niche Determinants.
Infect Immun
; 90(4): e0004822, 2022 04 21.
Artigo
Inglês
| MEDLINE | ID: mdl-35311544
4.
Invasive aspergillosis in relapsed/refractory acute myeloid leukaemia patients: Results from SEIFEM 2016-B survey.
Mycoses
; 65(2): 171-177, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-34695256
5.
Pharyngeal Microbial Signatures Are Predictive of the Risk of Fungal Pneumonia in Hematologic Patients.
Infect Immun
; 89(8): e0010521, 2021 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33782152
6.
Impact of invasive aspergillosis occurring during first induction therapy on outcome of acute myeloid leukaemia (SEIFEM-12B study).
Mycoses
; 63(10): 1094-1100, 2020 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-32697010
7.
'Real-life' analysis of the role of antifungal prophylaxis in preventing invasive aspergillosis in AML patients undergoing consolidation therapy: Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) 2016 study.
J Antimicrob Chemother
; 74(4): 1062-1068, 2019 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30649413
8.
COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA.
Blood
; 139(10): 1588-1592, 2022 03 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34748627
9.
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Infection
; 52(3): 1125-1141, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38388854
10.
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Infection
; 52(3): 1191-1194, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38771466
11.
Rhodotorula infection in haematological patient: Risk factors and outcome.
Mycoses
; 62(3): 223-229, 2019 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-30525252
12.
Febrile events in acute lymphoblastic leukemia: a prospective observational multicentric SEIFEM study (SEIFEM-2012/B ALL).
Ann Hematol
; 97(5): 791-798, 2018 May.
Artigo
Inglês
| MEDLINE | ID: mdl-29411126
13.
Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first-line therapy with hypomethylating agents alone or in combination with Venetoclax.
Am J Hematol
; 98(4): E80-E83, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36651870
14.
Invasive aspergillosis in acute myeloid leukemia: Are we making progress in reducing mortality?
Med Mycol
; 55(1): 82-86, 2017 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27915304
15.
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT.
Ann Hematol
; 99(1): 207-209, 2020 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-31832752
16.
Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey.
Int J Antimicrob Agents
; 61(6): 106806, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-37030470
17.
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry.
Front Immunol
; 14: 1125030, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36911708
18.
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry.
Ther Adv Hematol
; 14: 20406207231154706, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36923264
19.
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey.
Blood Adv
; 7(11): 2645-2655, 2023 06 13.
Artigo
Inglês
| MEDLINE | ID: mdl-37058479
20.
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings.
Int J Infect Dis
; 137: 98-110, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37863310